Never miss a Delaware County story!
ArriVent Biopharma in Newtown Square plans to initiate a public stock offering to raise between $137.5 million and $160 million for the development and…
Two Delaware County life science firms are leading the way this year in equity financing.
A cancer treatment drug being developed by ArriVent Biopharma in…
A public stock offering from Mineralys Therapeutics of Radnor netted $192 million for the company’s development of a new blood pressure drug candidate, lorundrostat…
Mineralys Therapeutics, a Radnor biopharmaceutical company is hoping to raise $100 million to develop a new high blood pressure treatment, writes John George for Philadelphia…
Mineralys Therapeutics in Radnor is on its way to developing a drug that will selectively treat hypertension, writes Laura Brzyski for Philadelphia Magazine.
Mineralys Therapeutics…
Before we send you to this site, please subscribe to our daily newsletter.